Related references
Note: Only part of the references are listed.Evaluation of Auto-Contouring and Dose Distributions for Online Adaptive Radiation Therapy of Patients With Locally Advanced Lung Cancers
Weihua Mao et al.
PRACTICAL RADIATION ONCOLOGY (2022)
MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges
Indrin J. Chetty et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases
Tugce Kutuk et al.
ADVANCES IN RADIATION ONCOLOGY (2022)
Covid-19 and radiotherapy: a systematic review after 2 years of pandemic
Antonio Piras et al.
CLINICAL AND TRANSLATIONAL IMAGING (2022)
Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer A Systematic Review and Meta-analysis
Eric J. Lehrer et al.
JAMA ONCOLOGY (2021)
VMAT-like plans for magnetic resonance guided radiotherapy: Addressing unmet needs
L. Placidi et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2021)
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases
Francesco Cuccia et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes
Fabian Weykamp et al.
FRONTIERS IN ONCOLOGY (2021)
Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience
Gamze Ugurluer et al.
RADIATION ONCOLOGY JOURNAL (2021)
Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Tumors
Tobias Finazzi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy
Sean M. O'Cathail et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient
Luca Boldrini et al.
FRONTIERS IN ONCOLOGY (2020)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
ICRU report91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery
Lotte Wilke et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2019)
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
Stephen A. Rosenberg et al.
ADVANCES IN RADIATION ONCOLOGY (2019)
Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial
Lauren E. Henke et al.
ADVANCES IN RADIATION ONCOLOGY (2019)
Technical design and concept of a 0.35 T MR-Linac
Sebastian Klueter
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen
Lauren Henke et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Prognostic factors in stereotactic body radiotherapy of lung metastases
K. J. Borm et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2018)
Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer
O. Bohoudi et al.
RADIOTHERAPY AND ONCOLOGY (2017)
The ViewRay System: Magnetic Resonance-Guided and Controlled Radiotherapy
Sasa Mutic et al.
SEMINARS IN RADIATION ONCOLOGY (2014)
Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus
Salma K. Jabbour et al.
PRACTICAL RADIATION ONCOLOGY (2014)
The Impact of Tumor Size on Outcomes After Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
Zishan Allibhai et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Stereotactic body radiotherapy for oligometastases
Alison C. Tree et al.
LANCET ONCOLOGY (2013)
The ICRU Report 83: Regulation, Documentation and Communication in the fluence of Modulated Photon radiotherapy (MRT)
N. Hodapp
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
CONSIDERATION OF DOSE LIMITS FOR ORGANS AT RISK OF THORACIC RADIOTHERAPY: ATLAS FOR LUNG, PROXIMAL BRONCHIAL TREE, ESOPHAGUS, SPINAL CORD, RIBS, AND BRACHIAL PLEXUS
Feng-Ming (Spring) Kong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Stereotactic body radiation therapy: The report of AAPM Task Group 101
Stanley H. Benedict et al.
MEDICAL PHYSICS (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Share Paper
